The Patent Finder

Biomunex Pharmaceuticals

Also on record
Records under this name other than the patents Biomunex Pharmaceuticals holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 3 of 3 · Back to Biomunex Pharmaceuticals

PatentTitleStatus Expires Confidence
17/791,549Multispecific Antibodies That Bind Both Mait and Tumor Cells
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/589,695Polypeptide Linker for Preparing Multispecific Antibodies
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
18/842,834Bispecific Antibodies Binding to HER-3 and to Either HER-2 or Egfr
Pending
Term is not computable until grant, so no date is shown and no estimate is implied.
PendingTerm is not computable until grant, so no date is shown and no estimate is implied.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited